Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

36 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
A phase III multisite randomised controlled trial to compare the efficacy of cannabidiol to placebo in the treatment of cannabis use disorder: the CBD-CUD study protocol.
Bhardwaj AK, Mills L, Doyle M, Sahid A, Montebello M, Monds L, Arunogiri S, Haber P, Lorenzetti V, Lubman DI, Malouf P, Harrod ME, Dunlop A, Freeman T, Lintzeris N. Bhardwaj AK, et al. Among authors: monds l. BMC Psychiatry. 2024 Mar 4;24(1):175. doi: 10.1186/s12888-024-05616-3. BMC Psychiatry. 2024. PMID: 38433233 Free PMC article.
The Australian Treatment Outcomes Profile instrument as a clinical tool for older alcohol and other drug clients: A validation study.
Lintzeris N, Monds LA, Rivas G, Leung S, Withall A, Draper B. Lintzeris N, et al. Drug Alcohol Rev. 2016 Nov;35(6):673-677. doi: 10.1111/dar.12393. Epub 2016 Apr 13. Drug Alcohol Rev. 2016. PMID: 27072851
Comparison with general older populations demonstrated the poorer health of this group of older AOD clients in particular.[Lintzeris N, Monds L A, Rivas G, Leung S, Withall A, Draper B. The Australian Treatment Outcomes Profile instrument as a clinical tool for olde …
Comparison with general older populations demonstrated the poorer health of this group of older AOD clients in particular.[Lintzeris N, M
Designing, implementing and evaluating the overdose response with take-home naloxone model of care: An evaluation of client outcomes and perspectives.
Lintzeris N, Monds LA, Bravo M, Read P, Harrod ME, Gilliver R, Wood W, Nielsen S, Dietze PM, Lenton S, Shanahan M, Jauncey M, Jefferies M, Hazelwood S, Dunlop AJ, Greenaway M, Haber P, Ezard N, Malcom A. Lintzeris N, et al. Drug Alcohol Rev. 2020 Jan;39(1):55-65. doi: 10.1111/dar.13015. Epub 2019 Nov 27. Drug Alcohol Rev. 2020. PMID: 31774221
New Australian guidelines for the treatment of alcohol problems: an overview of recommendations.
Haber PS, Riordan BC, Winter DT, Barrett L, Saunders J, Hides L, Gullo M, Manning V, Day CA, Bonomo Y, Burns L, Assan R, Curry K, Mooney-Somers J, Demirkol A, Monds L, McDonough M, Baillie AJ, Clark P, Ritter A, Quinn C, Cunningham J, Lintzeris N, Rombouts S, Savic M, Norman A, Reid S, Hutchinson D, Zheng C, Iese Y, Black N, Draper B, Ridley N, Gowing L, Stapinski L, Taye B, Lancaster K, Stjepanović D, Kay-Lambkin F, Jamshidi N, Lubman D, Pastor A, White N, Wilson S, Jaworski AL, Memedovic S, Logge W, Mills K, Seear K, Freeburn B, Lea T, Withall A, Marel C, Boffa J, Roxburgh A, Purcell-Khodr G, Doyle M, Conigrave K, Teesson M, Butler K, Connor J, Morley KC. Haber PS, et al. Among authors: monds l. Med J Aust. 2021 Oct 4;215 Suppl 7:S3-S32. doi: 10.5694/mja2.51254. Med J Aust. 2021. PMID: 34601742
36 results